Jelena S. Drulovic
Belgrade, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
Journal: Lancet (London, England)
Published: October 30, 2025
Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor.
Journal: International journal of molecular sciences
Published: September 30, 2025
Patterns of multimorbidity in persons with multiple sclerosis: Belgrade population registry data.
Journal: Neuroepidemiology
Published: August 23, 2025
Real-World Laboratory Analysis of Molecular Biomarkers in Multiple Sclerosis Centers in Central-Eastern European Countries Covering 107 Million Inhabitants.
Journal: International journal of molecular sciences
Published: July 20, 2025
Nationwide epidemiological study of neuromyelitis optica spectrum disorder in Serbia.
Journal: Multiple sclerosis and related disorders
Published: June 22, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.
Journal: JAMA neurology
Published: June 02, 2025
Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 report.
Journal: Multiple sclerosis and related disorders
Published: April 17, 2025
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 01, 2025
Costs of multiple sclerosis in Serbia.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: January 26, 2025
Increased burden of rare variants in GWAS associated genes in familial multiple sclerosis.
Journal: Scientific reports
Published: December 06, 2024
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists.
Journal: European journal of neurology
Published: September 12, 2024
Last Updated: 09/26/2026